Regulations in 2026 are stricter than ever to prevent counterfeit or stolen drugs from entering the medical system. In the United States, full enforcement of the DSCSA (Drug Supply Chain Security Act) requires "unit-level" traceability.

Every single bottle of medicine now has a unique digital "fingerprint." Using blockchain technology, a pharmacist can scan a bottle and see its entire history—from the factory where it was made to the truck that delivered it. This ensures that every medication given to a patient is authentic and safe. It also makes "recalls" much easier; if a specific batch of medicine is found to be faulty, the system can instantly identify exactly which hospitals have those specific bottles, allowing them to be removed from the shelves in minutes rather than days.